Skip main navigation

New offer! Get 30% off your first 2 months of Unlimited Monthly. Start your subscription for just £29.99 £19.99. New subscribers only. T&Cs apply

Find out more

Dosing Adjustment: Assumptions and Dosing Regimen

Dosing Adjustment: Assumptions and Dosing Regimen
In dealing with dosing adjustment in renal failure. We need to be cognizant of the assumptions. First, the assumptions related to the patient. We assume that renal failure patient and the otherwise normal patient share the same therapeutic concentration, nonrenal clearance, volume distribution, absorption and receptor sensitivity. Assumptions related to the drug itself. Now for renal failure patient, and otherwise normal patient The drug follows the same kinetic order. Or the drugs clearance is proportional to the creatinine clearance. And that the drug has the same tissue uptake. The assumptions or this assumptions are generally valid.
However, there are exceptions Therefore, a rational approach is to initiate the dosing regimen based on these absorptions followed by therapeutic drug monitoring and the so called “learn and adapt”. That during the learn and adapt process it may involve corrections for these assumptions. Now to keep the assumptions at the minimum, use patient specific PK information if available. Now, let’s look at the dosing regimen equation. Dosing regimen equations are derived based on IV infusion, or oral administration. Let’s start with constant rate intravenous infusion. Now if we infused a drug at constant rate for greater than 5 half-lives. Then the drug would reach at steady state. At the steady state, the concentration is equal to the infusion rate over the clearance.
Now if we assume same therapeutic concentration then, the equation is transformed into the second one which indicate that the infusion rate in uremic patient is equal to the uremic infusion rate in normal patient times the clearance ratio. Therefore, the correction factor is the clearance ratio. Again, here C is the steady-state concentration which is defined generally as the therapeutic concentration.
R: is the infusion rate.
Cl: is the total clearance.
and N: denotes normal kidney function.
U: denotes uremic. Now if derived to base on oral administration. By the same token if a drug is given orally on a chronic basis or on multiple dose basis then eventually the drug will reach at steady state concentration. At steady state, the rate of drug input is equal to the rate of drug output. Rate of drug input is a fraction of the dose divided by Tau dosing interval. The rate of output is clearance times steady state concentration. Sorry, I need to back up a little bit and that therefore the steady-state concentration or the average steady-state concentration is equal to F dose over clearance times Tau. Here again just quickly the definition or the denotation. F is bio-availability.
D is a dose. Tau is the dosing interval. Cl is the total clearance. and the Css is the average steady-state concentration.

In this step, Prof. Lee explains how to adjust the dosing regimen in renal failure.

If the IV infusion rate is constant, we can assume the same therapeutic concentration (Css), and use the relationship between infusion rate (R) and total clearance (Cl) to get what we want.

If the drug is administrated orally, we should consider the bioavailability (F), and use the final formula in this step to calculate its dosing regimen.

If you have any thoughts or questions about this part, please leave them below.

This article is from the free online

Pharmacokinetics: Drug Dosing in Renal Disease

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now